The global telemedicine market increased 35% from 2019 to 2020, exceeding $55bn. Forecasts suggest the market could reach nearly $300bn by 2028 (Source: "Telemedicine Market Size, Share & Trends Analysis Report By Component" Grand View Research, Feb 2021).
Structural Tailwinds
In 2019, an estimated half of the global population lacked essential health care services. As more underserved markets gain broadband access, telemedicine offers vast opportunity to bridge the divide (Source: World Economic Forum).
New Consumer Preferences
The pandemic increased adoption of digital health services, with many turning to telemedicine for the first time, accelerating the theme’s reach.
Capital at Risk. All financial investments involve an element of risk. Therefore, the value of your investment and the income from it will vary and your initial investment amount cannot be guaranteed.
ETF Summary
The Global X Telemedicine & Digital Health UCITS ETF (EDOC LN) seeks to invest
in companies positioned to benefit from further advances in the field of
telemedicine and digital health. This includes companies involved in
Telemedicine, Health Care Analytics, Connected Health Care Devices, and
Administrative Digitization.
ETF Objective
The Global X Telemedicine & Digital Health UCITS ETF (EDOC LN) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.
Trading Details
As of 02 Apr 2026
Primary Ticker
EDOC
Primary ISIN
IE00BLR6QB00
Bloomberg Index Ticker
SOLEDOC
Number of Holdings
40
Index Provider
Solactive AG
Management Style
Physical - Full Replication - Passively Managed Index Tracking
Regulatory
SFDR Classification
Article 6
UCITS Compliant
Yes
ISA Eligibility
Yes
SIPP Eligibility
Yes
UK Reporting Status
Yes
Authorized Participants & Market Makers
Citigroup Global Markets, DRW Europe BV, Flow Traders BV, GHCO LLP, HSBC Bank PLC, Jane Street Financial Ltd, Mirae Asset Securities UK Ltd, Societe Generale SA, Susquehanna Intl Ltd, Virtu Financial Ireland Ltd, JP Morgan Securities PLC
Top Holdings
As of 02 Apr 2026
Net Assets (%)
Ticker
Name
Country
SEDOL
Market Price ($)
Shares Held
Market Value ($)
6.43
ILMN
ILLUMINA INC
US
2613990
127.38
2,623
334,117.74
6.00
MASI
MASIMO CORP
US
B1YWR63
178.59
1,743
311,282.37
5.41
DGX
QUEST DIAGNOSTICS INC
US
2702791
197.16
1,426
281,150.16
5.30
LH
LABCORP HOLDINGS INC
US
BSBK800
273.72
1,005
275,088.60
5.21
TWST
TWIST BIOSCIENCE CORP
US
BGKG6G7
50.21
5,389
270,581.69
4.38
DXCM
DEXCOM INC
US
B0796X4
62.22
3,655
227,414.10
4.37
VCYT
VERACYTE INC
US
BFTWZY0
32.25
7,038
226,975.50
4.24
RMD
RESMED INC
US
2732903
224.09
982
220,056.38
3.98
PRVA
PRIVIA HEALTH GROUP INC
US
BMDP209
21.21
9,734
206,458.14
3.96
QGEN
QIAGEN N.V.
NL
BVPJWL3
41.03
5,017
205,847.51
Key Information
As of 02 Apr 2026
Inception Date
17 Dec 2020
Total Expense Ratio
0.68%
Ongoing Charges
0.68%
Fund AUM
$5,192,874.95
Factsheet
Domicile
Ireland
Investment Manager
Global X Management Company LLC
Custodian
BBH
Asset Class
Equity
Distributions(Distributing Share Class Only)
Distribution Frequency
Semi-Annually
Distribution Calendar
Performance History
USD Accumulating
As of recent Month End & Quarter End (31 Mar 2026)
Distribution Calendar